Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FA2H |
| Upstream (Parents) |
|---|
| (<<) ALDOA → FA2H |
| (<<) ATP10B → FA2H |
| (<<) B3GNT3 → FA2H |
| (<<) HK2 → FA2H |
| (<<) PHLDA2 → FA2H |
| (<<) S100P → FA2H |
| (<<) TK1 → FA2H |
| (<<) TUBA4A → FA2H |
| (<<) VPS37B → FA2H |
| Downstream (Children) |
|---|
| FA2H → ATP2C2 (>>) |
| FA2H → BMP2 (>>) |
| FA2H → CXCL3 (>>) |
| FA2H → EFNB1 (>>) |
| FA2H → FOS (>>) |
| FA2H → GDF15 (>>) |
| FA2H → IRAK1 (>>) |
| FA2H → ITGA2 (>>) |
| FA2H → KCTD5 (>>) |
| FA2H → KHDRBS3 (>>) |
| FA2H → KLF4 (>>) |
| FA2H → MAPK3 (>>) |
| FA2H → PLEK2 (>>) |
| FA2H → SERPINB1 (>>) |
| FA2H → SFN (>>) |
| FA2H → SPINK5 (>>) |
| FA2H → STYK1 (>>) |
| FA2H → TFF1 (>>) |
